# TirseBioh

- **Website:** <https://tirsebioh.com>
- **Primary alias:** `tirsebioh.com`

## Description

TirseBioh is a leading brand in the field of endocrinology, recognized for its comprehensive scientific analysis of tirzepatide, a synthetic peptide developed by Eli Lilly. This innovative molecule operates as a dual agonist, targeting both GIP and GLP-1 receptors, a unique feature that sets it apart from traditional incretin-based therapies. TirseBioh specializes in providing in-depth educational resources and long-form analyses that explain the mechanisms, clinical trial findings, and efficacy related to tirzepatide, particularly in the context of diabetes management and obesity treatment. Their research-focused programs, SURPASS and SURMOUNT, are pivotal in assessing tirzepatide's impact on glycemic control and weight loss, respectively. TirseBioh aims to equip healthcare professionals and researchers with evidence-based insights into the drug’s effectiveness, tolerability, and regulatory status. By prioritizing a thorough understanding of the science behind tirzepatide, TirseBioh ensures that its audience is well-informed about the latest advancements in diabetes and obesity therapies.

## Industries

- ⛑ Health
- ⛑ Biotechnology and Pharmaceuticals _(under Health)_
- 🧪 Science and Education
- 🧪 Biology _(under Science and Education)_

## Colors

| Name | Hex | Theme |
| --- | --- | --- |
| Royal Blue | #2563eb | accent |
| Ebony | #0f172a | dark |
| Your Pink | #fecaca | light |

## Fonts

- var(--display) — asset _(custom)_

---

_Source: <https://brandfetch.com/tirsebioh.com>_
_See [/llms.txt](/llms.txt) for a full list of agent-readable pages, and [/auth.md](/auth.md) for how agents authenticate._